Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Orca Bio
AddedFeb 14, 2024
UpdatedJun 18, 2026
Orca Bio

Orca Bio

Series D

Orca Bio: A clinical-stage cell therapy firm innovating curative treatments for over 100 diseases.

HQ
Menlo Park, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to deliver curative medicine, Orca Bio is a clinical-stage cell therapy company focused on developing precision allogeneic cell therapies. The company aims to revolutionize the treatment of over 100 malignant and autoimmune diseases through its proprietary technologies. Orca Bio's innovative approach seeks to redefine traditional transplant processes, offering next-generation cell therapies that promise significantly improved patient outcomes.

Orca Bio has assembled a team of world-leading experts and technologists to drive its vision forward. The company has garnered attention for its promising clinical programs, including Orca-T and Orca-Q, which have shown positive data at the 65th ASH Annual Meeting. With its cutting-edge research and impactful clinical results, Orca Bio is poised to make a significant impact in the field of cell therapy, offering new hope to patients worldwide.

Orca Bio - Similar Companies

Orca Pharmaceuticals logo

Orca Pharmaceuticals

Orion BioScience logo

Orion BioScience

Platelet BioGenesis logo

Platelet BioGenesis

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

AlloCure logo

AlloCure

Outpace Bio logo

Outpace Bio

outpacebio.com

OrsoBio logo

OrsoBio

orsobio.com

Ocelot Bio logo

Ocelot Bio

ocelotbio.com

Catamaran Bio logo

Catamaran Bio

catamaranbio.com

LizarBio Therapeutics logo

LizarBio Therapeutics

Appia Bio logo

Appia Bio

appiabio.com

Celularity logo

Celularity

celularity.com

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Orna Therapeutics logo

Orna Therapeutics

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Orca Bio - Quick Facts

Who are Orca Bio's competitors?

Companies similar to Orca Bio include Orca Pharmaceuticals, Orion BioScience, Platelet BioGenesis and Cell BioEngines.

When was Orca Bio founded?

Orca Bio was founded in 2016.

Where is Orca Bio's headquarters located?

Orca Bio's headquarters is located in Menlo Park, CA, US.

When was Orca Bio's last funding round?

Orca Bio's most recent funding round was for $192M (USD) in June 2020.

How much has Orca Bio raised to-date?

As of Jun 17, 2020, Orca Bio has raised a total of $192M (USD).

How many employees does Orca Bio have?

Orca Bio has 124 employees as of Feb 5, 2024.

Orca Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cell Therapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified